Director, External Corporate Communications

Eupraxia Pharmaceuticals is seeking a dynamic Director of External Communications with extensive experience within the biotech/pharma space, with specific experience working at a development stage company with a Phase 2/3 product. This position will play a key role generating the external corporate communications strategy to ensure the company's evolving story is communicated effectively. This position will work across functional areas including commercial, investor relations, clinical, medical affairs, research and HR.

They will be the point person for generating, reviewing and deploying external communication initiatives across various mediums (with subject matter expertise assistance) and responsible for corporate communications across multiple channels and platforms, including press releases, traditional and social media and for ensuring consistency of communications between corporate and communications and communications at scientific conferences.

Chief Corporate Development Officer

Seattle, WA or Vancouver, BC

Candidates must be able to work in person from either our Seattle or Vancouver office a minimum of two days per week.

• Develop communication strategies and plans that effectively communicate corporate and product stories to external audiences.
• Partner and coordinate with the executive team and other functional team members in the overall stewardship of the corporate brand, positioning and messaging.
• Own the process of creating and update company's overarching narrative and message architecture, ensuring consistency across the website, investor materials, social channels, commercial and medical communications.
• Navigate the process of obtaining approval for the Corporate Branding strategy and content by the Executive Team and other key stakeholder

• Develop and draft external communications materials, including corporate website content, press releases, R&D Day and investor materials, working with the appropriate functional subject matter experts. Where materials contain scientific, clinical or medical content, work closely with the CMO and designated
• Clinical/Medical subject matter experts, who retain accountability for the scientific and medical content and interpretation.

• Contribute to the production of press releases, earnings releases, corporate updates, and clinical trial milestone announcements, in close coordination with the CFO, General Counsel, and CEO.
• Prepare briefing materials for quarterly earnings calls, investor conference presentations, and the annual report / MD&A narrative, working with IR counsel and the executive team.
• Develop talking points, Q&A documents across investor, media, and public forums, ensuring message discipline.
• Support the Investor Relations function on positioning materials, including the corporate deck, fact sheet, and website content, ensuring consistent, non-promotional, compliant messaging across all investor touchpoints.
• Coordinate with IR the external messaging calendar around clinical catalysts, ensuring alignment with continuous disclosure obligations and coordination with the company's disclosure committee.
• Manage corporate social media presence (Linked In, X/Twitter) with a consistent voice appropriate for a regulated public company.

• Provide writing and communications support, as requested, for scientific and medical materials including congress materials, advisory board materials, KOL communications, publications and disease-state education. Scientific and medical strategy, content and interpretation remain the responsibility of the
• Clinical/Medical organization.
• Ensure external communications containing scientific, clinical or medical information are appropriately reviewed and approved by the accountable
• Clinical/Medical and other relevant functional leaders before external use.
• Maintain working fluency in the disease areas and competitive landscape, drawing on market research and competitive analysis of the competitive and scientific landscape to sharpen external messaging and anticipate questions from analysts and media.

• Supporting the commercial function in defining key messages and supporting proof points for each priority audience: gastroenterologists, allergists/immunologists, pediatric subspecialists, patients and caregivers, payers, investors, and internal stakeholders. Ensure messaging is…